Stricturing Crohn’s disease-like colitis in a patient treated with belatacept
Open Access
- 28 December 2017
- journal article
- case report
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 23 (48) , 8660-8665
Abstract
Stricturing Crohn’s disease-like colitis in a patient treated with belataceptKeywords
This publication has 11 references indexed in Scilit:
- Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized TrialAmerican Journal of Kidney Diseases, 2017
- Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumabAnnals of Oncology, 2017
- Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel DiseaseJournal of Crohn's and Colitis, 2016
- Endoscopic and histological features of mycophenolate mofetil colitis in patients after solid organ transplantation2015
- Two cases of ulcerative colitis developing in rheumatoid arthritis patients during abatacept therapyScandinavian Journal of Gastroenterology, 2014
- Abatacept for Crohn's Disease and Ulcerative ColitisGastroenterology, 2012
- A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)American Journal of Transplantation, 2010
- Case Report: Human herpesvirus 6 reactivation associated with colitis in a lung transplant recipientJournal of Medical Virology, 2008
- Ulcerative colitis during CTLA-4Ig therapy in a patient with rheumatoid arthritis: Table 1Gut, 2006
- Impact of human herpesvirus‐6 after haematopoietic stem cell transplantationBritish Journal of Haematology, 2004